Comment on

• ACE-inhibitors: panacea for progressive renal disease.

  Navis G, de Zeeuw D, de Jong PE. Navis G, et al. Lancet. 1997 Jun 28;349(9069):1852-3. doi: 10.1016/s0140-6736(97)22026-x. Lancet. 1997. PMID: 9217751 No abstract available.
• Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia).

  [No authors listed] [No authors listed] Lancet. 1997 Jun 28;349(9069):1857-63. Lancet. 1997. PMID: 9217756 Clinical Trial.
• When should ACE inhibitors be given to normotensive patients with IDDM.

  Wang PH. Wang PH. Lancet. 1997 Jun 21;349(9068):1782-3. doi: 10.1016/S0140-6736(97)22025-8. Lancet. 1997. PMID: 9269206 No abstract available.
• Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria. The EUCLID Study Group.

  [No authors listed] [No authors listed] Lancet. 1997 Jun 21;349(9068):1787-92. Lancet. 1997. PMID: 9269212 Clinical Trial.